Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Why do children with severe bronchopulmonary dysplasia not attend neonatal follow-up care? Parental views of barriers.

Brady JM, Pouppirt N, Bernbaum J, D'Agostino JA, Gerdes M, Hoffman C, Cook N, Hurt H, Kirpalani H, DeMauro SB.

Acta Paediatr. 2018 Jun;107(6):996-1002. doi: 10.1111/apa.14265. Epub 2018 Mar 8.

PMID:
29420848
2.

Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003.

Kobaly K, Schluchter M, Minich N, Friedman H, Taylor HG, Wilson-Costello D, Hack M.

Pediatrics. 2008 Jan;121(1):73-81. doi: 10.1542/peds.2007-1444.

PMID:
18166559
3.

Parents' experiences of transition when their infants are discharged from the Neonatal Intensive Care Unit: a systematic review protocol.

Aagaard H, Uhrenfeldt L, Spliid M, Fegran L.

JBI Database System Rev Implement Rep. 2015 Oct;13(10):123-32. doi: 10.11124/jbisrir-2015-2287.

PMID:
26571288
4.

Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL.

Cochrane Database Syst Rev. 2017 Oct 24;10:CD001146. doi: 10.1002/14651858.CD001146.pub5. Review.

5.

Longitudinal assessment of the lung mechanics of very low birth weight preterm infants with and without bronchopulmonary dysplasia.

Mello RR, Silva KS, Costa AM, Ramos JR.

Sao Paulo Med J. 2015 Sep-Oct;133(5):401-7. doi: 10.1590/1516-3180.2014.00101812. Epub 2015 Oct 9.

6.

Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.

Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD.

Pediatrics. 2009 Jun;123(6):1541-7. doi: 10.1542/peds.2008-1670.

PMID:
19482766
7.

Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.

Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL.

Cochrane Database Syst Rev. 2017 Oct 24;10:CD001145. doi: 10.1002/14651858.CD001145.pub4. Review.

8.

Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program.

Poindexter BB, Feng R, Schmidt B, Aschner JL, Ballard RA, Hamvas A, Reynolds AM, Shaw PA, Jobe AH; Prematurity and Respiratory Outcomes Program.

Ann Am Thorac Soc. 2015 Dec;12(12):1822-30. doi: 10.1513/AnnalsATS.201504-218OC.

9.

A pulmonary score for assessing the severity of neonatal chronic lung disease.

Madan A, Brozanski BS, Cole CH, Oden NL, Cohen G, Phelps DL.

Pediatrics. 2005 Apr;115(4):e450-7.

PMID:
15805348
10.

Home oxygen promotes weight gain in infants with bronchopulmonary dysplasia.

Groothuis JR, Rosenberg AA.

Am J Dis Child. 1987 Sep;141(9):992-5.

PMID:
3618573
11.

Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, Wrage LA, Poole K; National Institutes of Child Health and Human Development Neonatal Research Network.

Pediatrics. 2005 Dec;116(6):1353-60.

PMID:
16322158
12.

Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates.

Isayama T, Lee SK, Yang J, Lee D, Daspal S, Dunn M, Shah PS; Canadian Neonatal Network and Canadian Neonatal Follow-Up Network Investigators.

JAMA Pediatr. 2017 Mar 1;171(3):271-279. doi: 10.1001/jamapediatrics.2016.4141.

PMID:
28114678
13.

Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.

Laughon MM, Langer JC, Bose CL, Smith PB, Ambalavanan N, Kennedy KA, Stoll BJ, Buchter S, Laptook AR, Ehrenkranz RA, Cotten CM, Wilson-Costello DE, Shankaran S, Van Meurs KP, Davis AS, Gantz MG, Finer NN, Yoder BA, Faix RG, Carlo WA, Schibler KR, Newman NS, Rich W, Das A, Higgins RD, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

Am J Respir Crit Care Med. 2011 Jun 15;183(12):1715-22. doi: 10.1164/rccm.201101-0055OC. Epub 2011 Mar 4.

14.

Ophthalmological morbidity in very-low-birthweight infants with bronchopulmonary dysplasia.

Ajayi OA, Raval D, Lucheese N, Pildes RS.

J Natl Med Assoc. 1997 Oct;89(10):679-83.

15.

Does chronic oxygen dependency in preterm infants with bronchopulmonary dysplasia at NICU discharge predict respiratory outcomes at 3 years of age?

Lodha A, Ediger K, Rabi Y, Lodha S, Tang S, Bhandari A, Sauve R, Bhandari V.

J Perinatol. 2015 Jul;35(7):530-6. doi: 10.1038/jp.2015.7. Epub 2015 Feb 26.

PMID:
25719546
16.
17.

Home oxygen therapy in infants with bronchopulmonary dysplasia: a prospective study.

Baraldi E, Carra S, Vencato F, Filippone M, Trevisanuto D, Milanesi O, Pinello M, Zanardo V, Zacchello F.

Eur J Pediatr. 1997 Nov;156(11):878-82.

PMID:
9392405
19.

Predicting death or tracheostomy placement in infants with severe bronchopulmonary dysplasia.

Murthy K, Savani RC, Lagatta JM, Zaniletti I, Wadhawan R, Truog W, Grover TR, Zhang H, Asselin JM, Durand DJ, Short BL, Pallotto EK, Padula MA, Dykes FD, Reber KM, Evans JR.

J Perinatol. 2014 Jul;34(7):543-8. doi: 10.1038/jp.2014.35. Epub 2014 Mar 20.

PMID:
24651732
20.

Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.

Lapcharoensap W, Gage SC, Kan P, Profit J, Shaw GM, Gould JB, Stevenson DK, O'Brodovich H, Lee HC.

JAMA Pediatr. 2015 Feb;169(2):e143676. doi: 10.1001/jamapediatrics.2014.3676. Epub 2015 Feb 2.

PMID:
25642906

Supplemental Content

Support Center